Inventor

Hideo Kobayashi

Inventor
Saitama, JP

Overview

22→
Patents
1992–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
A61KPreparations for medical, dental or toiletry purposes16%
H04NPictorial communication, e.g. television9%
H10FInorganic semiconductor devices sensitive to infrared radiation, light, electromagnetic radiation of shorter wavelength or corpuscular radiation7%
H01LSemiconductor devices5%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds4%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds4%
H05KPrinted circuits4%
A61MDevices for introducing media into, or onto, the body2%
PatentTitleYear
11,129,974Fine hollow protrusion implement202111,134,212Photoelectric conversion device, imaging system, and moving unit202111,115,593Lens interchangeable digital camera, and operation method and operation program thereof202111,109,494Display device202111,108,985Imaging device, imaging system, and movable object202111,108,986Semiconductor apparatus and equipment202111,100,603Controller202111,064,145Imaging device, imaging system, and moving body20219,095,600'Prophylactic and/or therapeutic agent for cardiac infarction'20159,040,536'Substituted pyrrolo[1,2-a]quinoxalines as PDE9 inhibitors'20158,920,832'Composition for nucleic acid transfection'20148,829,000'Substituted imidazo[1,5-A]quinoxalines as phosphodiesterase 9 inhibitors'20148,377,944'Thienopyrimidine derivatives'20138,299,080'Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor'20128,293,754'Thienopyrimidine derivatives'20128,227,248'Composition for nucleic-acid transfection'20127,557,123'Heterocyclic compound and medicinal use thereof'20096,872,732'Heterocyclic derivatives and medicinal use thereof'20056,861,071'Highly absorptive solid preparation'20056,589,963'Heterocyclic compounds and salts thereof and medicinal use of the same'20035,202,360'Fluorine-containing alicyclic and aromatic cyclic compounds, process thereof and adhesive composition containing the compound'19935,157,148'Fluorine-containing alicyclic and aromatic cyclic compounds, process thereof and adhesive composition containing the compound'1992

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1992–1993Based in Settsu, JP· patent location history
2003–2009Based in Uji, JP· patent location history
2005–2021Based in Tokyo, JP· patent location history
2012–2015Patents assigned to KOBAYASHI HIDEO (7)· patent assignee history
2012–2015Patents assigned to ASKA PHARM CO LTD (5)· patent assignee history
2012–2014Patents assigned to GOTANDA KOTARO (4)· patent assignee history
2012–2014Patents assigned to NAKANO YOUICHI (4)· patent assignee history
2012–2021Based in Saitama, JP· patent location history
2012–2015Based in Edogawa-ku, JP· patent location history
2021Patents assigned to CANON KK (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
KOBAYASHI HIDEOself72012–2015
ASKA PHARM CO LTD52012–2015
CANON KK42021
GOTANDA KOTARO42012–2014
NAKANO YOUICHI42012–2014
Locations
LocationPatentsSpan
Saitama, JP62012–2021
Tokyo, JP52005–2021
Edogawa-ku, JP32012–2015
Uji, JP32003–2009
Settsu, JP21992–1993